Profile data is unavailable for this security.
About the company
Sihuan Pharmaceutical Holdings Group Ltd is a holding company mainly engaged in pharmaceutical manufacturing business. The Company operates three segments. Medical Aesthetic Products segment includes the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetics comprehensive solutions. Innovative Medicine and Other Medicine segment is engaged in the research and development of innovative drugs in the fields of digestion, oncology, non-alcoholic hepatitis, diabetes and complications. The Company also operates Generic Medicine segment.
- Revenue in HKD (TTM)2.01bn
- Net income in HKD-58.27m
- Incorporated2006
- Employees2.87k
- LocationSihuan Pharmaceutical Holdings Group Ltd21/F, Building 2,Zhbng 2000 Bsns CtrWest BalizhuangChaoyang DistrictBEIJING 100025ChinaCHN
- Phone+86 75 588609726
- Fax+86 1 052278758
- Websitehttp://www.sihuanpharm.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CARsgen Therapeutics Holdings Ltd | 0.00 | -806.63m | 3.83bn | 516.00 | -- | 1.97 | -- | -- | -1.45 | -1.45 | 0.00 | 3.38 | 0.00 | -- | -- | 0.00 | -29.79 | -- | -32.14 | -- | -- | -- | -- | -- | 9.54 | -- | 0.0452 | -- | -- | -- | 16.19 | -- | -- | -- |
| Biocytogen Pharmaceuticals Beijng Co Ltd | 773.31m | -413.08m | 3.83bn | 1.07k | -- | 4.52 | -- | 4.95 | -1.04 | -1.04 | 1.94 | 2.12 | 0.2732 | 16.21 | 5.74 | 725,435.90 | -14.59 | -- | -18.88 | -- | 70.59 | -- | -53.42 | -- | 1.24 | -21.30 | 0.4077 | -- | 34.28 | -- | 36.38 | -- | -- | -- |
| CK Life Sciences Intl (Holdings) Inc | 5.32bn | 17.25m | 3.89bn | 1.93k | 226.26 | 0.9292 | 34.33 | 0.7313 | 0.0018 | 0.0018 | 0.5538 | 0.4359 | 0.4728 | 2.96 | 4.74 | 2,755,038.00 | 0.1532 | 1.11 | 0.211 | 1.43 | 30.76 | 30.52 | 0.3241 | 2.42 | 0.8512 | 0.8796 | 0.5861 | 59.00 | 0.8936 | 0.3407 | -86.93 | -42.01 | 0.2784 | -- |
| Beijing Luzhu Biotechnology Co Ltd | 0.00 | -268.97m | 4.14bn | 133.00 | -- | 3.76 | -- | -- | -1.34 | -1.34 | 0.00 | 5.44 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 6.41 | -- | 0.0185 | -- | -- | -- | 65.62 | -- | -- | -- |
| Jiangsu Recbio Technology Co Ltd | 0.00 | -616.96m | 4.35bn | 472.00 | -- | 3.73 | -- | -- | -1.28 | -1.28 | 0.00 | 2.41 | 0.00 | -- | -- | 0.00 | -25.47 | -- | -30.68 | -- | -- | -- | -- | -- | 2.33 | -- | 0.378 | -- | -- | -- | 20.86 | -- | -- | -- |
| Alphamab Oncology | 235.99m | -227.16m | 4.64bn | 435.00 | -- | 2.57 | -- | 19.67 | -0.2362 | -0.2362 | 0.2458 | 1.87 | 0.1028 | 0.7705 | 19.34 | 542,496.40 | -9.90 | -18.72 | -11.69 | -21.94 | 74.75 | -- | -96.26 | -415.55 | 5.55 | -- | 0.1333 | -- | 31.12 | -- | 35.35 | -- | -13.12 | -- |
| Ocumension Therapeutics | 265.75m | -409.67m | 4.73bn | 444.00 | -- | 1.49 | -- | 17.80 | -0.6313 | -0.6313 | 0.4094 | 4.56 | 0.078 | 3.61 | 2.12 | 598,535.60 | -12.03 | -38.78 | -13.21 | -41.47 | 58.60 | 62.30 | -154.16 | -975.82 | 3.72 | -- | 0.0451 | -- | 54.99 | -- | 5.68 | -- | 319.66 | -- |
| Shandong Boan Biotechnology Co Ltd | 666.76m | -128.77m | 4.99bn | 813.00 | -- | 3.51 | -- | 7.49 | -0.2528 | -0.2528 | 1.31 | 2.80 | 0.2732 | 1.35 | 2.53 | 820,123.00 | -5.28 | -- | -7.02 | -- | 66.16 | -- | -19.31 | -- | 0.8383 | -7.47 | 0.2491 | -- | 19.80 | -- | 64.02 | -- | -- | -- |
| Microport NeuroTech Ltd | -100.00bn | -100.00bn | 5.29bn | 571.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 21.61 | -- | 768.73 | -- | -- | -- |
| Sihuan Pharmaceutical Holdings Group Ltd | 2.01bn | -58.27m | 5.32bn | 2.87k | -- | 1.11 | -- | 2.65 | -0.0063 | -0.0063 | 0.2159 | 0.5124 | 0.1572 | 0.8101 | 4.72 | 698,786.90 | -2.18 | -6.85 | -3.34 | -9.10 | 69.64 | 75.81 | -13.85 | -36.23 | 1.35 | -2.63 | 0.1863 | -- | -14.70 | -8.60 | 97.23 | -- | 0.9325 | -- |
| Ascentage Pharma Group International | 239.45m | -998.46m | 5.34bn | 583.00 | -- | 81.93 | -- | 22.30 | -3.53 | -3.53 | 0.8482 | 0.2246 | 0.0833 | 2.38 | 2.22 | 410,717.80 | -34.73 | -44.93 | -52.82 | -57.04 | 86.24 | 87.68 | -417.02 | -976.10 | 1.42 | -15.03 | 0.9622 | -- | 5.85 | 100.76 | -4.84 | -- | 2.82 | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | -100.00bn | -100.00bn | 5.54bn | 145.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -28.25 | -- | 5.82 | -- | -- | -- |
| Consun Pharmaceutical Group Ltd | 2.79bn | 846.26m | 5.69bn | 3.13k | 6.57 | 1.44 | 6.11 | 2.04 | 1.06 | 1.06 | 3.50 | 4.82 | 0.4981 | 2.08 | 9.10 | 893,473.30 | 15.13 | 12.04 | 22.57 | 19.25 | 74.19 | 74.55 | 30.37 | 24.89 | 2.62 | -- | 0.1155 | 41.53 | 10.71 | 7.03 | 14.88 | 11.01 | -- | 18.43 |
| Shanghai Fudan-Zhangjiang Bio-Pharm. Co | 872.90m | 110.23m | 6.20bn | 948.00 | 19.61 | 0.8551 | -- | 7.10 | 0.1071 | 0.1071 | 0.829 | 2.46 | 0.2852 | 1.44 | 1.62 | 920,779.30 | 3.59 | 7.03 | 4.35 | 9.05 | 91.40 | 92.17 | 12.59 | 17.26 | 3.94 | 568.37 | 0.0062 | 39.16 | -17.50 | 2.78 | -21.28 | -0.6326 | 20.49 | 0.00 |
| Qyuns Therapeutics Co Ltd | 0.00 | -547.69m | 6.25bn | 331.00 | -- | 19.66 | -- | -- | -2.47 | -2.47 | 0.00 | 1.43 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 1.64 | -69.52 | 0.5349 | -- | -- | -- | -70.28 | -- | -- | -- |
| New Horizon Health Ltd | 1.47bn | 119.33m | 6.47bn | 1.04k | 59.22 | 2.01 | 41.65 | 4.41 | 0.2388 | 0.2388 | 3.22 | 7.04 | 0.4536 | 2.16 | 2.08 | 1,673,276.00 | 3.67 | -- | 3.99 | -- | 88.74 | -- | 8.10 | -- | 10.50 | -- | 0.1305 | -- | 259.54 | -- | 97.40 | -- | -- | -- |
Data as of May 28 2024. Currency figures normalised to Sihuan Pharmaceutical Holdings Group Ltd's reporting currency: Hong Kong Dollar HKD
4.51%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 09 May 2024 | 151.02m | 1.62% |
| BlackRock Fund Advisorsas of 09 May 2024 | 61.00m | 0.65% |
| Dimensional Fund Advisors LPas of 09 May 2024 | 59.10m | 0.63% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 56.02m | 0.60% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2022 | 32.73m | 0.35% |
| China Asset Management Co., Ltd.as of 31 Dec 2023 | 19.07m | 0.20% |
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 15.12m | 0.16% |
| BlackRock Advisors (UK) Ltd.as of 09 May 2024 | 14.36m | 0.15% |
| SSgA Funds Management, Inc.as of 09 May 2024 | 6.52m | 0.07% |
| American Century Investment Management, Inc.as of 09 May 2024 | 5.53m | 0.06% |
More ▼
Data from 31 Dec 2023 - 22 May 2024Source: FactSet Research Systems Inc.
